Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer
Clinical trial NCT02751385 · TERMINATED
Trial details
- NCT number
- NCT02751385
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-20
- Primary completion
- 2017-11-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.